Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
grade A 96.48 0.46% 0.44
ABBV closed up 0.46 percent on Thursday, October 19, 2017, on 1.39 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Oct 27

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABBV trend table...

Date Alert Name Type % Chg
Oct 19 New 52 Week High Other 0.00%
Oct 19 New 52 Week Closing High Bullish 0.00%
Oct 19 Upper Bollinger Band Walk Other 0.00%
Oct 18 New 52 Week High Other 0.46%
Oct 18 Wide Range Bar Range Expansion 0.46%

Older signals for ABBV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 96.44
52 Week Low 53.6576
Average Volume 6,611,515
200-Day Moving Average 69.3869
50-Day Moving Average 82.1722
20-Day Moving Average 89.8056
10-Day Moving Average 92.0113
Average True Range 1.8338
ADX 47.88
+DI 40.17
-DI 8.96
Chandelier Exit (Long, 3 ATRs ) 91.1186
Chandelier Exit (Short, 3 ATRs ) 88.1151
Upper Bollinger Band 95.8814
Lower Bollinger Band 83.7298
Percent B (%b) 1.05
BandWidth 13.531005
MACD Line 3.2258
MACD Signal Line 3.0279
MACD Histogram 0.1979
Fundamentals Value
Market Cap 153.8 Billion
Num Shares 1.59 Billion
EPS 4.07
Price-to-Earnings (P/E) Ratio 23.71
Price-to-Sales 5.38
Price-to-Book 23.92
PEG Ratio 1.15
Dividend 2.56
Dividend Yield 2.65%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 99.65
Resistance 3 (R3) 99.34 97.98 99.12
Resistance 2 (R2) 97.98 97.17 98.13 98.94
Resistance 1 (R1) 97.23 96.68 97.61 97.54 98.77
Pivot Point 95.87 95.87 96.06 96.02 95.87
Support 1 (S1) 95.12 95.06 95.50 95.43 94.19
Support 2 (S2) 93.76 94.57 93.91 94.02
Support 3 (S3) 93.01 93.76 93.84
Support 4 (S4) 93.32